infringement after 2005
-- Also ruled that the Oregon federal district court will not stay the
injunction pending Arthrex's appeal
The disputed patent covers use of Smith & Nephew's BIORAPTOR, TAG(TM)
WEDGE, and TAG ROD suture anchors, which are designed to help repair
instability in the shoulder as well as other soft tissue tears. The Arthrex
products that were found to infringe these patents are: Bio-SutureTak, PEEK
SutureTak, and Bio-PushLock and PEEK PushLock suture anchors which are used
in various soft tissue repair surgeries, including shoulder repair surgery.
Contact: Joe Metzger
Sr. Vice President, Corporate Communications
Smith & Nephew Endoscopy
Smith & Nephew is a global medical technology business, specializing in Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2007 were nearly $3.4 billion.
This press release contains certain "forward-looking statements" within
the meaning of the U.S. Private Securities Litigation Reform Act of 1995.
In particular, statements regarding planned growth in our business and in
our operating margins discussed under "Outlook" are forward-looking
statements as are discussions of our product pipeline.
|SOURCE Smith & Nephew Inc.|
Copyright©2008 PR Newswire.
All rights reserved